ABINGDON HEALTH PLC Financials Abingdon Health Plc
Equities
ABDX
GB00BLF79J41
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.856 GBX | -1.44% |
|
-6.13% | -10.40% |
| Mar. 25 | Peel Hunt's RetailBook raises GBP2.5 million | AN |
| Mar. 25 | Abingdon Health Completes Design Freeze for STD Self-Tests | MT |
Valuation
| Fiscal Period: June | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 138.1 | 33.87 | 36.95 |
| Enterprise Value (EV) 1 | 134.7 | 32.76 | 34.74 |
| P/E ratio | -19.5 x | -1.57 x | -10.5 x |
| Yield | - | - | - |
| Capitalization / Revenue | 11.9 x | 11.9 x | 9.14 x |
| EV / Revenue | 11.6 x | 11.6 x | 8.59 x |
| EV / EBITDA | -27.2 x | -3.09 x | -11.7 x |
| EV / FCF | -7,983,918 x | -14,387,586 x | 15,358,466 x |
| FCF Yield | -0% | -0% | 0% |
| Price to Book | 6.39 x | 5.2 x | 12.1 x |
| Nbr of stocks (in thousands) | 281,932 | 307,945 | 307,950 |
| Reference price 2 | 0.4900 | 0.1100 | 0.1200 |
| Announcement Date | 11/29/21 | 11/24/22 | 10/17/23 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 5.235 | 11.62 | 2.835 | 4.045 |
| EBITDA 1 | 0.278 | -4.942 | -10.59 | -2.966 |
| EBIT 1 | 0.217 | -5.372 | -11.86 | -3.594 |
| Operating Margin | 4.15% | -46.24% | -418.52% | -88.85% |
| Earnings before Tax (EBT) 1 | -3.375 | -6.954 | -21.59 | -3.556 |
| Net income 1 | -3.374 | -6.973 | -21.26 | -3.451 |
| Net margin | -64.45% | -60.02% | -749.98% | -85.32% |
| EPS | - | -0.0251 | -0.0699 | -0.0114 |
| Free Cash Flow | - | -16.87 | -2.277 | 2.262 |
| FCF margin | - | -145.18% | -80.31% | 55.91% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 11/29/21 | 11/29/21 | 11/24/22 | 10/17/23 |
1GBP in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | 0.38 | - | - | - |
| Net Cash position 1 | - | 3.48 | 1.12 | 2.22 |
| Leverage (Debt/EBITDA) | 1.381 x | - | - | - |
| Free Cash Flow | - | -16.9 | -2.28 | 2.26 |
| ROE (net income / shareholders' equity) | - | -57.9% | -153% | -73.1% |
| ROA (Net income/ Total Assets) | - | -15.2% | -32.2% | -23.9% |
| Assets 1 | - | 45.89 | 65.94 | 14.47 |
| Book Value Per Share | - | 0.0800 | 0.0200 | 0.0100 |
| Cash Flow per Share | - | 0.0200 | 0.0100 | 0.0100 |
| Capex 1 | 1.65 | 6.76 | 0.68 | 0.08 |
| Capex / Sales | 31.52% | 58.19% | 24.06% | 1.85% |
| Announcement Date | 11/29/21 | 11/29/21 | 11/24/22 | 10/17/23 |
1GBP in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -10.40% | 38.65M | |
| +0.99% | 12.95B | |
| -7.57% | 7.84B | |
| +3.02% | 5.5B | |
| +0.93% | 4.61B | |
| +8.48% | 4.61B | |
| +9.21% | 2.66B | |
| -14.07% | 2.08B | |
| -11.63% | 1.72B | |
| +3.45% | 1.79B |
- Stock Market
- Equities
- ABDX Stock
- Financials Abingdon Health Plc
